# Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

> **NCT07652684** · PHASE4 · RECRUITING · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 74 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia (BPD)

## Interventions

- **DIETARY_SUPPLEMENT:** Enteral supplementation with ARA and DHA (in a 2:1 ratio) in addition to standard care and feeding
- **OTHER:** Standard care and feeding

## Key facts

- **NCT ID:** NCT07652684
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-04
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-03-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652684, "Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*